Construction and evaluation of Fe₃O₄-based PLGA nanoparticles carrying rtPA used in the detection of thrombosis and in targeted thrombolysis.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  ACS Applied Materials and Interfaces

• Publication date

  2014-04-02

• Fields of study

  Medicine, Materials Science, Engineering

• Identifiers
  DOI 10.1021/am406008kPMID 24693875
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fibrin-targeted PET probes for the detection of thrombi.

  2013cited by this paper
• Troubleshooting the rabbit ferric chloride-induced arterial model of thrombosis to assess in vivo efficacy of antithrombotic drugs.

  2013cited by this paper
• Preparation and characterization of gadolinium-loaded PLGA particles surface modified with RGDS for the detection of thrombus

  2013cited by this paper
• Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging.

  2012cited by this paper
• Bioconjugation of recombinant tissue plasminogen activator to magnetic nanocarriers for targeted thrombolysis

  2012cited by this paper
• Molecular imaging of fibrin deposition in deep vein thrombosis using fibrin-targeted near-infrared fluorescence.

  2012cited by this paper
• Preparation and in vitro evaluation of doxorubicin-loaded Fe3O4 magnetic nanoparticles modified with biocompatible copolymers

  2012cited by this paper
• PLGA-based nanoparticles: an overview of biomedical applications.

  2012cited by this paper
• Targeted delivery of tissue plasminogen activator by binding to silica-coated magnetic nanoparticle

  2012cited by this paper
• Molecular MRI of Thrombosis

  2011cited by this paper
• Magnetic resonance in the era of molecular imaging of cancer.

  2011cited by this paper
• Characterization of chitosan magnetic nanoparticles for in situ delivery of tissue plasminogen activator

  2011cited by this paper
• Gd-DTPA-loaded PLGA microbubbles as both ultrasound contrast agent and MRI contrast agent--a feasibility research.

  2010cited by this paper
• The characteristics, biodistribution, magnetic resonance imaging and biodegradability of superparamagnetic core-shell nanoparticles.

  2010cited by this paper
• Construction of thrombus-targeted microbubbles carrying tissue plasminogen activator and their in vitro thrombolysis efficacy: a primary research

  2010cited by this paper
• Noninvasive visualization of in vivo release and intratumoral distribution of surrogate MR contrast agent using the dual MR contrast technique.

  2010cited by this paper
• Gelatin/chitosan/hyaluronan scaffold integrated with PLGA microspheres for cartilage tissue engineering.

  2009cited by this paper
• Experimental study of the preparation of targeted microbubble contrast agents carrying urokinase and RGDS.

  2009cited by this paper
• Magnetically targeted thrombolysis with recombinant tissue plasminogen activator bound to polyacrylic acid-coated nanoparticles.

  2009cited by this paper
• Molecular MRI of early thrombus formation using a bimodal alpha2-antiplasmin-based contrast agent.

  2009cited by this paper
• In vitro and in vivo platelet targeting by cyclic RGD-modified liposomes.

  2009cited by this paper
• The t-PA-encapsulated PLGA nanoparticles shelled with CS or CS-GRGD alter both permeation through and dissolving patterns of blood clots compared with t-PA solution: an in vitro thrombolysis study.

  2009cited by this paper
• Platelet and endothelial adhesion on fluorosurfactant polymers designed for vascular graft modification.

  2009cited by this paper
• Poly(Lactic-co-Glycolic) Acid as a Carrier for Imaging Contrast Agents

  2009cited by this paper
• Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agents of magnetic resonance and ultrasound imaging.

  2009cited by this paper
• Chemical conjugation of urokinase to magnetic nanoparticles for targeted thrombolysis.

  2009cited by this paper
• Preparation and initial characterization of biodegradable particles containing gadolinium-DTPA contrast agent for enhanced MRI

  2008cited by this paper
• Encapsulation and release of plasminogen activator from biodegradable magnetic microcarriers.

  2008cited by this paper
• Overview of murine thrombosis models.

  2008cited by this paper
• Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles.

  2008cited by this paper
• Ligand-directed nanobialys as theranostic agent for drug delivery and manganese-based magnetic resonance imaging of vascular targets.

  2008cited by this paper
• Magnetic Resonance Imaging Contrast Agent Targeted Toward Activated Platelets Allows In Vivo Detection of Thrombosis and Monitoring of Thrombolysis

  2008cited by this paper
• Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles.

  2008cited by this paper
• Affinity manipulation of surface-conjugated RGD peptide to modulate binding of liposomes to activated platelets.

  2008cited by this paper
• Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody.

  2007cited by this paper
• MR contrast agents, the old and the new.

  2006cited by this paper
• Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory.

  2006cited by this paper
• In vitro release of vascular endothelial growth factor from gadolinium‐doped biodegradable microspheres

  2004cited by this paper
• Therapeutic applications of microbubbles.

  2002cited by this paper
• High‐resolution MRI characterization of human thrombus using a novel fibrin‐targeted paramagnetic nanoparticle contrast agent

  2000cited by this paper

• Magnetic drug-loaded microbubbles for treating lower limb venous thrombosis under controllable rotating magnetic field

  2025cites this paper
• Nanoparticle delivery systems mitigate hemorrhagic complications following tPA-induced thrombolysis

  2025cites this paper
• Nanoparticles for Thrombolytic Therapy in Ischemic Stroke: A Systematic Review and Meta-Analysis of Preclinical Studies

  2025cites this paper
• Dual-responsive and NIR-triggered detachable nanoplatform for integrated thrombolytic and antiplatelet therapy

  2025cites this paper
• Toxicity Challenges and Current Advancement in Metal–Organic Frameworks (MOFs) for Biomedical Applications

  2025cites this paper
• Engineered immune-driven theranostics for clinical cardiology

  2025cites this paper
• RGD-decorated nanoparticles: Therapeutic potential beyond cancer

  2024cites this paper
• Magnetic nanoparticles and their hybrid biomaterials for drug delivery and theranostic applications in cardiovascular diseases

  2024cites this paper
• Peptide-based targeting: Novel concept for thrombosis diagnosis and treatment

  2024cites this paper
• Multiscale physics-based in silico modelling of nanocarrier-assisted intravascular drug delivery

  2024cites this paper
• Metal‐based smart nanosystems in cancer immunotherapy

  2024cites this paper
• Development a novel nano-platform for Thrombolysis acceleration by Thrombin sensitive polymer-peptide hybrid nancapsules.

  2024cites this paper
• Cutting-edge advances in nano/biomedicine: A review on transforming thrombolytic therapy.

  2024cites this paper
• Fibrinogen binding to activated platelets and its biomimetic thrombus-targeted thrombolytic strategies.

  2024cites this paper
• Micro/nanodevice-loaded minimally invasive robot for hematoma evacuation: A novel technology for primary brainstem hemorrhage treatment

  2024cites this paper
• Chitosan-Based Nanoformulations: Preclinical Investigations, Theranostic Advancements, and Clinical Trial Prospects for Targeting Diverse Pathologies

  2024cites this paper
• Anticoagulant Macromolecules

  2023cites this paper
• Colchicine delivered by a novel nanoparticle platform alleviates atherosclerosis by targeted inhibition of NF-κB/NLRP3 pathways in inflammatory endothelial cells

  2023cites this paper
• Iron Nanoparticles Open Up New Directions for Promoting Healing in Chronic Wounds in the Context of Bacterial Infection

  2023cites this paper
• The Recent Applications of PLGA-Based Nanostructures for Ischemic Stroke

  2023cites this paper
• Application of magnetic iron oxide nanoparticles: Thrombotic activity, imaging and cytocompatibility of silica-coated and carboxymethyl dextrane-coated particles.

  2023cites this paper
• Application of nanotechnology in thrombus therapy.

  2023cites this paper
• Focusing and rotating magnetic nanoparticle clusters for fast ablation of thrombus

  2023cites this paper
• Magnetic Nanoparticles Mediated Thrombolysis–A Review

  2023cites this paper
• RGD peptide modified RBC membrane functionalized biomimetic nanoparticles for thrombolytic therapy

  2023cites this paper
• Evolving Diagnostic and Management Advances in Coronary Heart Disease

  2023cites this paper
• Magnetic Response Combined with Bioactive Ion Therapy: A RONS-Scavenging Theranostic Nanoplatform for Thrombolysis and Renal Ischemia-Reperfusion Injury.

  2023cites this paper
• Harnessing nanotechnology for cardiovascular disease applications - a comprehensive review based on bibliometric analysis

  2022cites this paper
• Nanomaterials: A Promising Therapeutic Approach for Cardiovascular Diseases

  2022cites this paper
• Molecular nanoprobes for diagnosis of cardiovascular diseases

  2022cites this paper
• Ultrasound and Magnetic Dual-Mode Stacked Transducer for Sonothrombolysis with a Combination of Nanodroplets and Magnetic Nanoparticles

  2022cites this paper
• Targeted thrombolysis by magnetoacoustic particles in photothrombotic stroke model

  2022cites this paper
• Thrombus-targeted nano-agents for NIR-II diagnostic fluorescence imaging-guided flap thromboembolism multi-model therapy

  2022cites this paper
• Nanomaterials-based imaging diagnosis and therapy of cardiovascular diseases

  2022cites this paper
• Urokinase loaded black phosphorus nanosheets for sequential thrombolysis and reactive oxygen species scavenging in ischemic stroke treatment.

  2022cites this paper
• Platelet Membrane Cloaked Nanotubes to Accelerate Thrombolysis by Thrombus Clot-Targeting and Penetration.

  2022cites this paper
• Recent Advances in Nanomaterials for Diagnosis, Treatments, and Neurorestoration in Ischemic Stroke

  2022cites this paper
• Impact of surface chemistry of ultrasmall superparamagnetic iron oxide nanoparticles on protein corona formation and endothelial cell uptake, toxicity, and barrier function.

  2022cites this paper
• Magnet-Guided Bionic System with LIFU Responsiveness and Natural Thrombus Tropism for Enhanced Thrombus-Targeting Ability

  2022cites this paper
• Theranostic nanoparticles for the management of thrombosis

  2022influential citation
• Iron Oxide Nanoparticles in Regenerative Medicine and Tissue Engineering

  2021cites this paper
• Recent Advances in the Development of Theranostic Nanoparticles for Cardiovascular Diseases

  2021influential citation
• Nanotechnology combining photoacoustic kinetics and chemical kinetics for thrombosis diagnosis and treatment

  2021cites this paper
• SPIONs and magnetic hybrid materials: Synthesis, toxicology and biomedical applications

  2021cites this paper
• Rescuing Ischemic Stroke by Biomimetic Nanovesicles through Accelerated Thrombolysis and Sequential Ischemia-Reperfusion Protection.

  2021cites this paper
• Fucoidan-functionalized polysaccharide submicroparticles loaded with alteplase for efficient targeted thrombolytic therapy.

  2021cites this paper
• New Approaches in Nanomedicine for Ischemic Stroke

  2021cites this paper
• Smart Delivery of Plasminogen Activators for Efficient Thrombolysis; Recent Trends and Future Perspectives

  2021cites this paper
• Nanomaterials in Cerebrovascular Disease Diagnose and Treatment

  2021cites this paper
• Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke

  2021influential citation
• Inhibition of cancer-associated thrombosis with redox-sensitive paclitaxel/heparin-deoxycholic acid nanoparticles

  2021cites this paper
• Thrombolytic Agents: Nanocarriers in Targeted Release

  2021cites this paper
• Synthetic high-density lipoproteins loaded with an antiplatelet drug for efficient inhibition of thrombosis in mice

  2020cites this paper
• Synthesis and Evaluation of a Novel Nanoparticle Carrying Urokinase Used in Targeted Thrombolysis.

  2020cites this paper
• An in vitro Model System for Evaluating Remote Magnetic Nanoparticle Movement and Fibrinolysis

  2020cites this paper
• Preparation of Peptide and Recombinant Tissue Plasminogen Activator Conjugated Poly(Lactic-Co-Glycolic Acid) (PLGA) Magnetic Nanoparticles for Dual Targeted Thrombolytic Therapy

  2020cites this paper
• Nano-Medicine for Thrombosis: A Precise Diagnosis and Treatment Strategy

  2020cites this paper
• GSH ‐responsive polyglutamic acid nanocarriers for dual targeted cancer therapy

  2020cites this paper
• Accelerating thrombolysis using a precision and clot-penetrating drug delivery strategy by nanoparticle-shelled microbubbles

  2020cites this paper
• Thrombolytic Agents: Nanocarriers in Controlled Release.

  2020cites this paper
• Nanomedicine progress in thrombolytic therapy.

  2020cites this paper
• Multimodal and multifunctional nanoparticles with platelet targeting ability and phase transition efficiency for the molecular imaging and thrombolysis of coronary microthrombi.

  2020cites this paper
• Self-Assembled Hybrid Nanocomposites for Multimodal Imaging-Guided Photothermal Therapy of Lymph Node Metastasis.

  2020cites this paper
• Magnetically assisted imprinted sensor for selective detection antibiotics in river based on surface-enhanced Raman scattering

  2020cites this paper
• Incorporation of Gadolinium Oxide and Gadolinium Oxysulfide Microspheres: MRI/CT Monitoring and Promotion of Osteogenic/Chondrogenic Differentiation for Bone Implants

  2020cites this paper
• An activated-platelet-sensitive nanocarrier enables targeted delivery of tissue plasminogen activator for effective thrombolytic therapy.

  2019cites this paper
• SR-A-Targeted Phase-Transition Nanoparticles for the Detection and Treatment of Atherosclerotic Vulnerable Plaques.

  2019cites this paper
• Early diagnosis of cerebral thrombosis by EGFP–EGF1 protein conjugated ferroferric oxide magnetic nanoparticles

  2019cites this paper
• Near-Infrared Light Activated Thermosensitive Ion Channel to Remotely Control Transgene System for Thrombolysis Therapy.

  2019cites this paper
• AIEgen based poly(L-lactic-co-glycolic acid) magnetic nanoparticles to localize cytokine VEGF for early cancer diagnosis and photothermal therapy

  2019cites this paper
• Co-encapsulation of magnetic Fe3O4 nanoparticles and doxorubicin into biocompatible PLGA-PEG nanocarriers for early detection and treatment of tumours

  2019cites this paper
• Development of nanomedicines for inflammation disorders : evaluation of pharmacological efficacy on preclinical models

  2019cites this paper
• Cyclic RGD functionalized liposomes targeted to activated platelets for thrombosis dual-mode magnetic resonance imaging.

  2019cites this paper
• Recent strategies on targeted delivery of thrombolytics

  2019cites this paper
• Low-Intensity Focused Ultrasound-Responsive Phase-Transitional Nanoparticles for Thrombolysis without Vascular Damage: A Synergistic Nonpharmaceutical Strategy.

  2019cites this paper
• Nanoparticle Therapy for Vascular Diseases

  2019cites this paper
• Preclinical Evaluation and Clinical Translation of Magnetite-Based Nanomedicines

  2019cites this paper
• Polydopamine-modified dual-ligand nanoparticles as highly effective and targeted magnetic resonance/photoacoustic dual-modality thrombus imaging agents

  2019cites this paper
• Sol-gel composites based on alumina and ferria for cardiovascular diseases treatment

  2019cites this paper
• Therapeutic Aspects of Nanomedicines in Stroke Treatment

  2019cites this paper
• Targeted thrombolysis by using c-RGD-modified N,N,N-Trimethyl Chitosan nanoparticles loaded with lumbrokinase

  2018cites this paper
• Urokinase-Conjugated Magnetite Nanoparticles as a Promising Drug Delivery System for Targeted Thrombolysis: Synthesis and Preclinical Evaluation.

  2018cites this paper
• Tissue Plasminogen Activator-Porous Magnetic Microrods for Targeted Thrombolytic Therapy after Ischemic Stroke.

  2018cites this paper
• Recombinant Tissue Plasminogen Activator-conjugated Nanoparticles Effectively Targets Thrombolysis in a Rat Model of Middle Cerebral Artery Occlusion

  2018cites this paper
• Thrombolytic therapy based on fucoidan-functionalized polymer nanoparticles targeting P-selectin.

  2018cites this paper
• Multiarm-polyethylene glycol-polyglutamic acid peptide dendrimer: Design, synthesis, and dissolving thrombus.

  2018cites this paper
• Construction of polylysine dendrimer nanocomposites carrying nattokinase and their application in thrombolysis.

  2018cites this paper
• The Multifaceted Uses and Therapeutic Advantages of Nanoparticles for Atherosclerosis Research

  2018cites this paper
• Iron Oxide Loaded PLGA Particles for Contrast Enhancement in Magnetic Resonance Imaging (MRI)

  2017influential citation
• Annexin V-Conjugated Mixed Micelles as a Potential Drug Delivery System for Targeted Thrombolysis.

  2017cites this paper
• Phase Transition Nanoparticles as Multimodality Contrast Agents for the Detection of Thrombi and for Targeting Thrombolysis: in Vitro and in Vivo Experiments.

  2017cites this paper
• Sequential delivery of chlorhexidine acetate and bFGF from PLGA-glycol chitosan core-shell microspheres.

  2017cites this paper
• Nanoplumbers: biomaterials to fight cardiovascular diseases

  2017cites this paper
• Conception de vecteurs polymères pour l’imagerie moléculaire et le traitement ciblé de la thrombose

  2017cites this paper
• Polyester Nano- and Microsystems for Vaccine Delivery

  2017cites this paper
• Fe3O4-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis

  2017cites this paper
• Magnetic nanobubbles with potential for targeted drug delivery and trimodal imaging in breast cancer: an in vitro study.

  2017cites this paper
• Evaluation of PLGA containing anti‐CTLA4 inhibited endometriosis progression by regulating CD4+CD25+Treg cells in peritoneal fluid of mouse endometriosis model

  2017cites this paper
• Magnetically controlled release of recombinant tissue plasminogen activator from chitosan nanocomposites for targeted thrombolysis.

  2016cites this paper
• Fibrinolytic PLGA nanoparticles for slow clot lysis within abdominal aortic aneurysms attenuate proteolytic loss of vascular elastic matrix.

  2016cites this paper